Home » Topics » Regulatory » Patents

Patents
RSS

Enanta Pharmaceuticals identifies respiratory syncytial virus inhibitors

Aug. 1, 2018

New kinase inhibitors developed at IMPACT Therapeutics

Aug. 1, 2018

BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group

July 30, 2018

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical identify A2A receptor antagonists

July 30, 2018

CV6 Therapeutics presents deoxyuridine nucleotidohydrolase inhibitors

July 30, 2018

Influenza RNA-directed RNA polymerase inhibitors patented by Sunshine Lake Pharma

July 30, 2018

Minoryx Therapeutics patents beta-1 galactosidase mutant chaperones

July 27, 2018

Meiji Seika Pharma identifies phosphodiesterase PDE4 inhibitors

July 27, 2018

Viamet Pharmaceuticals describes cytochrome P450 11B2 inhibitors

July 27, 2018

Henan Metab Biopharma divulges Mcl-1 inhibitors

July 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026